Skip to content
★ Sign in to follow
Genetic Signatures Limited logo

Genetic Signatures Limited Stock: price and insider trades · Australia

ISIN AU000000GSS4AU·Mcap A$17.7MHealth Care

Genetic Signatures Limited: what insiders have been doing

Genetic Signatures Limited is a Health Care company. Its directors and officers file their transactions with ASX. The last twelve months, up to 2 November 2026, brought 13 filings signed by 11 insiders.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Over the last twelve months, not one insider purchase of Genetic Signatures Limited stock was filed. The median gap between a trade and its publication by ASX is 3 days. That lag is the time during which only the insider knows about the trade.

With 13 filings in twelve months, the company is more active than the median of 5 filings across the 1,612 companies we follow on the same exchange.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Source: insider filings from ASX. Past trades are no guide to future returns.

Insider Decl.
13
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 26,124 of 26,914 companies
12.0
score / 100
Value
3
Quality
21
FCF yld-55%
Earn yld-87%
EV/EBITDA·
ROE-33%
Gross mgn35%
Net mgn-97%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended June 2026 · cache

A$0.08
Analyst consensus
1 analysts
·
A$0.31Target A$0.31(+297%)A$0.31
Income statement
RevenueA$14.5M
Gross profitA$5M35% margin
EBITDA-A$15.7M-108% margin
Net income-A$14M-72.5% margin
Valuation
PER (forward)-1.7x
P/Book0.5x
Beta0.63
Balance sheet & cash
Market capA$17.7M
Total debtA$310k
Free Cash Flow-A$8.8M
Debt / Equity1%
Profitability & ownership
ROE-32.6%
ROA-17.3%
% insiders28.2%
% institutions40.8%
Last declaration on 1 November 2026
Declarations13 total
  • ●
    DirectorExecutives(filed)
    0ASX
    ShareASXISIN AU000000GSS4ASX:2924-03156840-2A1707704
  • ●
    Related company / holdingExecutives
    0ASX
    ShareASXISIN AU000000GSS4ASX:2924-03140707-2A1699824
  • ●
    DirectorExecutives(filed)
    0ASX
    ShareASXISIN AU000000GSS4ASX:2924-03130132-2A1694187
  • ●
    Related company / holdingExecutives
    0ASX
    ShareASXISIN AU000000GSS4ASX:2924-03127528-2A1692853
  • ●
    Related company / holdingExecutives(filed)
    0ASX
    ShareASXASX:2924-03126068-2A1692079
  • ●
    Substantial HolderExecutives(filed)
    0ASX
    ShareASXISIN AU000000GSS4ASX:2924-03125696-2A1691843
  • ●
    Related company / holdingExecutives
    0ASX
    ShareASXASX:2924-03107151-2A1681941
  • ●
    Executives
    Executives(filed)
    0ASX
  • ●
    Substantial HolderExecutives(filed)
    0ASX
    ShareASXISIN AU000000GSS4ASX:2924-03101628-2A1678096
  • ●
    Executives
    Executives(filed)
    0ASX
  • ●
    DirectorExecutives(filed)
    0ASX
    ShareASXASX:2924-03088041-2A1671113
  • ●
    Executives
    Executives(filed)
    0ASX
  • ●
    Executives
    Executives(filed)
    0ASX

13 of 13 declarations

About Genetic Signatures Limited

Genetic Signatures Limited is a company listed on the Australian Securities Exchange, specializing in the development of diagnostic tests based on DNA technology. It focuses on the rapid and accurate detection of pathogens in clinical samples.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations